Home Sequential Compression Devices Market to reach US$ 1,572.81 million by 2028 - Leading companies Biocompression Systems; DSMAREF, AIROS Medical; Breg, Tactile Medical

The home sequential compression device (SCD) is a DVT prevention device that increases leg blood flow. SCDs are in the shape of "sleeves" that wrap around the legs and inflate one at a time using air. This simulates walking and aids in the prevention of blood clots. When you're in bed or sitting in a chair, the one should wear SCDs. For walking, the SCDs must be removed. The home sequential compression devices market is expected to witness a significant growth in the coming years owing to the factors such as rise prevalence of lymphatic and venous disorders and increasing awareness about the advance treatment involve use of sequential compression and other devices are driving the market growth. However, availability of alternate therapies hampers the growth of the market.

The home sequential compression devices market was valued at US$ 992.49 million in 2021 and is projected to reach US$ 1,572.81 million by 2028; it is expected to grow at a CAGR of 6.8% from 2021 to 2028.

Request for sample copy at: https://www.theinsightpartners.com/sample/TIPRE00019265/?openpr-10144

Cardinal Health Inc; Biocompression Systems; DJO Global, Inc.; DSMAREF CO.LTD; Precision Medical Products; AIROS Medical; Breg Inc.; Mego Afek ltd.; Arjo Medical Devices; and Tactile Medical, Inc are among the leading companies operating in the home sequential compression devices market.

Based on by device type, the home sequential compression devices market is segmented into alternate sequential compression device (ASCD), simultaneous sequential compression device (SSCD). The simultaneous sequential compression device (SSCD) segment held the largest share of the market in 2021, and same segment is anticipated to register the highest CAGR in the market during the forecast period. Factors such as a factor such as rise prevalence of lymphatic and venous disorders and increasing awareness about the advance treatment involve use of sequential compression and other devices are driving the market growth. However, availability of alternate therapies hampers the growth of the market.

Due to growing demand for COVID related medical devices many companies have been prioritizing sales in their respective segments. For instance, in response to the coronavirus pandemic leading market players in compression therapy devices have been collaborating with suppliers to understand and manage the impact of the pandemic on product supply. For instance, Cardinal health has been partnering with trade groups including Health Industry Distributors Association (HIDA), Healthcare Distribution Alliance (HDA), National Community Pharmacists Association (NCPA), National Association of Chain Drug Stores (NACDS), Healthcare Ready, and AdvaMed to respond to industry wide challenges. Such a strategic initiatives will boost the home care devices market.

Moreover, remote patient monitoring (RPM) in COVID-19 crisis offers tools for disease monitoring and patient-provider communications that reduce infection risks for patients, communities, and providers. These are especially safe and useful method of care as healthcare system works to combat COVID-19. Thus, owing to the above–mentioned factors, the pandemic has shown a positive impact on the home medical devices market, which will support the home sequential compression devices market.

Sequential compression devices (SCDs) are used as a part of venous thromboembolism (VTE). As per the Center for Disease Control and Prevention (CDC), blood clotting in a deep vein results in the VTE, which is primarily a condition of blood vessels. These clots generally develop in lower leg, thigh, or pelvis, and injury to veins, slow blood flow, increased estrogen levels, heart diseases, and obesity are among the main causes of the clot formation. As per a study published by StatPearls Publishing LLC in August 2020, more than 200,000 people in the US are reported to develop venous thrombosis annually. Moreover, as per the Thrombosis UK, 1 in 1000 people suffer from venous thrombosis every year. Venous disorders are caused due to factors such as pregnancy, obesity, varicose vein, and venous insufficiency. Venous insufficiency is observed in pregnancy mainly due to an enlarged gravid uterus, resulting in hypertension in the lower extremity veins and increased hormone secretion, weakening the vein walls. Thus, the rising prevalence of lymphatic and venous disorders is boosting the demand for home sequential compression device, thereby driving the market growth.

Place an Order Copy at: https://www.theinsightpartners.com/buy/TIPRE00019265/?openpr-10144

About Us:
We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.

Contact Us
Phone: +1-646-491-9876
Email: sales@theinsightpartners

This release was published on openPR.